- Home
- AOUT vs PLX Comparison
AOUT vs PLX Comparison
Compare AOUT & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOUT
- PLX
- Stock Information
- Founded
- AOUT 2020
- PLX 1993
- Country
- AOUT United States
- PLX United States
- Employees
- AOUT N/A
- PLX N/A
- Industry
- AOUT Ordnance And Accessories
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AOUT Industrials
- PLX Health Care
- Exchange
- AOUT Nasdaq
- PLX Nasdaq
- Market Cap
- AOUT 133.2M
- PLX 127.4M
- IPO Year
- AOUT N/A
- PLX 1998
- Fundamental
- Price
- AOUT $8.66
- PLX $1.84
- Analyst Decision
- AOUT Strong Buy
- PLX Strong Buy
- Analyst Count
- AOUT 2
- PLX 1
- Target Price
- AOUT $15.00
- PLX $15.00
- AVG Volume (30 Days)
- AOUT 82.7K
- PLX 692.9K
- Earning Date
- AOUT 09-04-2025
- PLX 11-13-2025
- Dividend Yield
- AOUT N/A
- PLX N/A
- EPS Growth
- AOUT N/A
- PLX N/A
- EPS
- AOUT N/A
- PLX 0.08
- Revenue
- AOUT $210,381,000.00
- PLX $61,948,000.00
- Revenue This Year
- AOUT N/A
- PLX $14.53
- Revenue Next Year
- AOUT $7.08
- PLX $75.77
- P/E Ratio
- AOUT N/A
- PLX $23.89
- Revenue Growth
- AOUT 5.56
- PLX 62.79
- 52 Week Low
- AOUT $8.10
- PLX $0.99
- 52 Week High
- AOUT $17.91
- PLX $3.10
- Technical
- Relative Strength Index (RSI)
- AOUT 38.21
- PLX 61.90
- Support Level
- AOUT $8.68
- PLX $1.52
- Resistance Level
- AOUT $9.06
- PLX $1.69
- Average True Range (ATR)
- AOUT 0.39
- PLX 0.09
- MACD
- AOUT -0.10
- PLX 0.03
- Stochastic Oscillator
- AOUT 21.71
- PLX 71.11
About AOUT American Outdoor Brands Inc.
American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.